| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GLOBAL BLOOD THERAPEUTICS IN COM | 14,760,900 | 622,320,000 | 58.10% | ||
| 2 | SAGE THERAPEUTICS | 6,442,916 | 272,664,000 | 25.46% | ||
| 3 | BLUEPRINT MEDICINES CORP COM | 7,393,059 | 157,768,000 | 14.73% | ||
| 4 | ELEVEN BIOTHERAPEUTICS INC | 4,841,591 | 11,668,000 | 1.09% | ||
| 5 | ZAFGEN INC COM | 210,371 | 6,721,000 | 0.63% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001600135-15-000001, filed 2015.11.03).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
